SGLT-2-i: consider for all CKD patients

Targeted early detection measures and timely treatment of chronic kidney disease (CKD) are extremely important to halt progression and manage complications. The determination of albuminuria makes it possible to make the diagnosis earlier than by looking at the eGFR alone. The SGLT-2 inhibitors originally developed for the treatment of diabetes are not only cardioprotective, but also counteract the progression of renal function loss.